Cleopatra Hospital Company · EGX:CLHO
Cleopatra Hospital — Cleopatra Hospitals Group — Investor Presentation (2026)
62 slides from Cleopatra Hospital's investor presentation, 2026
Slide 1: Transforming Healthcare in Egypt
Transforming Healthcare in Egypt Investor Presentation FY 2025
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements, including, but not limited to, statements concerning expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating
Slide 3: Contents
CONTENTS 1 Cleopatra Hospitals Group Highlights 2 Macro Environment 3 Competitive Advantages 4 Growth Strategy & New Business 5 Governance & Management Information 6 FY 2025 in Review 7 Appendix
Slide 4: Cleopatra Hospitals Group Highlights
Cleopatra Hospitals Group Highlights 4
Slide 5: CHG Mission, Vision and Values
CHG Mission, Vision and Values ➢ A Patient-First Approach to Healthcare Our Mission • Delivering Leading Quality Services • Ensuring Safety of all Stakeholders • Growing Beds Supply & Expanding their Distribution • Improving Quality of Lives Everyday ➢ Sustainable Growth & Cross-Asset Collaboration
Slide 6: Broad Network Across Greater Cairo and Beyond
Broad Network Across Greater Cairo and Beyond, Penetrating Underserved Regions Leveraging a growing footprint, CHG continues to penetrate new segments of the population and provide high quality care to underserved regions across Greater Cairo Leveraging a growing footprint, CHG continues to penetrat
Slide 7: Cementing Impact Today & Scaling for the Future
Cementing Impact Today & Scaling for the Future Performance Progression (EGP mn) CAGR 2015-2019 2019-2022 2022-2025 Revenue 45% 13% 40% Gross Profit 45% 12% 48% EBITDA 41% 12% 44% Net Profit 40% 10% 39% Institutionalization and Building the Foundation Agile Business Model Business Leverage 8,000 7,2
Slide 8: Record Breaking Results for FY 2025
Record Breaking Results for FY 2025 2025 was a year of substantial FY 2025 Snapshot operational and strategic progress for the Group. The Group achieved consolidated revenues of EGP 7.2 billion, an increase of 33% year- EGP 7,227 mn EGP 2,858 mn on-year, and served 1.5 million Consolidated revenues
Slide 9: Fast Growing, Diversified Healthcare Services Provider
Fast Growing, Diversified Healthcare Services Provider Group Revenue, EBITDA and Margins | EGP mn Revenue CAGR: 25% 7,227 5,420 1,907 29.6% 1,588 3,595 28.2% 2,137 1,063 26.6% 23.0% 26.5% 26.0% 27.9% 27.1% 2,549 29.9% 2,614 27.1% 1,529 422 438 1,798 502 1,990 540 763 709 954 276 2019 2020 2021 202
Slide 10: Macro Environment
Macro Environment 10
Slide 11: Growing Population & Prevalence of Lifestyle Diseases
Growing Population & Prevalence of Lifestyle Diseases Demographics Common Illnesses Breast Cancer Cases Communicable Diseases Lung Cancer Cases CAGR 3% 382,642 Cases CAGR 3% Acute Respiratory illness 33,863 Cases Chicken Pox 7,521 Cases 23,081 40,544 11,945 Brucella 6,045 2018 2040 2018 2040 • The m
Slide 12: Egypt's Healthcare Market Structure
Egypt’s Healthcare Market Structure Hospitals by Governorate and Geographical Disparities Medical Services in the Region EGYPT GCC MENA • Healthcare facilities are highly • Doctor/1,000 population ratio for concentrated in Cairo, Alexandria, Egypt is higher than both MENA Daqahleya & Giza which toge
Slide 13: Healthcare Investments in Egypt
Healthcare Investments in Egypt Private Sector as a % of total Healthcare Expenditure (2023) Government Spending 62% Government Healthcare Expenditure % of Total Expenditure 56% 58% 6.8% 4.7% 4.8% 5.2% 40% 39% 34% 36% 23% 21% 2018 2019 2020 2021 15% • Egypt’s House of Representatives approved budget
Slide 14: Competitive Advantages
P 7, -e . ae >» _ Benpstve 4 lam end = vantages
Slide 15: A leading healthcare services platform with sustainable competitive advantages
A leading healthcare services platform with sustainable competitive advantages CHG was a pioneering force in Egypt's private healthcare sector, recognizing its potential early on. The Group introduced an innovative 360-degree integrated management system, focused on delivering quality patient care a
Slide 16: CHG's Centers of Excellence are built on key pillars
CHG’s Centers of Excellence are built on key pillars that drive consistent, high-quality performance Defining Centers of Excellence Select Examples of CHG’s Centers of Excellence Competitive Defined Scope & Nursing & Residents Advantage & Sales Focus Team Differentiation Consumables Medical Equipmen
Slide 17: Growth Strategy & New Business
Growth Strategy & New Business 17
Slide 18: Core growth strategy driving sustainable expansion and value creation
CHG advances its strategic agenda through a clearly defined core growth strategy – Driving sustainable expansion and value creation Integrating the platform to Leveraging payor and achieve higher efficiencies supplier relationships Geographic expansion in Egypt Enhancing utilization and linked to fo
Slide 19: 2026 Strategy: Foundation For Sustainable Growth & Financial Strength
2026 Strategy: Foundation For Sustainable Growth & Financial Strength Pricing to Follow Inflation Leverage Trends Maintain on Organic Competitive Hospitals Edge Deleverage Enhanced Cash Minimum Capex & Maintain Conversion Cycle Capital Invest minimal capex in 2026 limited to the Framework 1) Higher
Slide 20: Expanding West Cairo: Cleopatra October Hospital
Expanding West Cairo: Cleopatra October Hospital – CHG’s Flagship Asset Facility Overview Cleopatra October Current Facility + Extension Building • Transformed by CHG into a world-class tertiary hospital specialized in orthopedics, spine, rehabilitation & sports injuries (largest COEs in Egypt & MEN
Slide 21: Cleopatra October Hospital: Exceeding Revenue & Margin Expectations
Cleopatra October Hospital: Consistently Exceeding Revenue & Margin Expectations Cleopatra October Hospital is progressing well in its ramp-up phase following its transformation into a full-scale tertiary musculoskeletal hospital Cleopatra October Hospital, CHG’s Total Revenues | EGP mn Gross Profit
Slide 22: Cleopatra El-Tagamoa Hospital
Strengthening Presence in Underserved Regions: Cleopatra El-Tagamoa Hospital • In line with CHG’s strategy to expand into underserved regions, the Group launched a top-tier hospital in East Cairo and introduced 240 new beds to the market starting end of 2025. • Operates under an asset-light, 25-year
Slide 23: Cleopatra El-Tagamoa Hospital: Grand Inauguration
Cleopatra El-Tagamoa Hospital: Grand Inauguration with Egypt’s National Leadership The Prime Minister witnesses the inauguration of Cleopatra El-Tagamoa Hospital, a milestone in public private partnership and advanced medical care. 23
Slide 24: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital Entrances 24
Slide 25: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital Reception Atrium 25
Slide 26: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital CHG Academy and Auditorium 26
Slide 27: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital Emergency Room Outpatient Clinics Pharmacy OPD 27
Slide 28: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital Operating Room Inpatient Room 28
Slide 29: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital Pharmacy Dialysis 29
Slide 30: The Grand Inauguration of Cleopatra El-Tagamoa Hospital
The Grand Inauguration of Cleopatra El-Tagamoa Hospital Dentistry CCU 30
Slide 31: Launch of Maadi Polyclinics
Launch of Maadi Polyclinics as a referral hub for Nile Badrawi Hospital Description: • A multi-specialty polyclinic facility with 30 clinics, with diagnostics & physiotherapy services • Launched in February 2026 Scope: • Expand and increase the market share of CHG in Maadi & Mokattam areas. • Increa
Slide 32: Governance & Management Information
Governance & Management Information 32
Slide 33: Best-in-class corporate governance standards
CHG employs best-in-class corporate governance standards that are in line with the highest international standards… OPERATIONS ABC No Referral Fees Medical Council • CHG has a zero-tolerance approach to bribery and • CHG does not pay any referral fees or kickbacks to • CHG recently launched a group-
Slide 34: Board of directors
… supported by a board of directors dominated by experienced independent and non- executive directors and focused on growing shareholder value… The Group’s Board of Directors provide the necessary oversight and combination of expertise to thoroughly oversee the Group’s corporate governance framework
Slide 35: Experienced management team
… and led by a highly competent and ambitious management team comprised of accomplished industry veterans with vast experience in the healthcare sector The Group is managed by a seasoned team that brings along deep industry experience to their respective positions gained in leading regional and mult
Slide 36: FY 2025 in Review
FY 2025 in Review 36
Slide 37: Our Strategy drives consistent long-term value
Our Strategy drives consistent long-term value Cases Outpatient Inpatients Surgeries Revenues Served Visits 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 12.4% 10.8% 15.2% 5.0% 40.3% FY 2025: FY 2025: FY 2025: FY 2025: FY 2025: 1,472,534 75,107 1,204,807 43,415 EGP 7,227mn Y-o-Y G
Slide 38: FY 2025 Financial Performance Overview
FY 2025 Financial Performance Overview FY 2025 Snapshot ▪ CHG reported consolidated revenues of EGP 7,227mn in FY 2025, up 33% year-on-year, and EGP 1,907mn in the last quarter of the year, up 20% year-on-year. ▪ In both FY 2025 and Q4 2025, CHG successfully expanded its gross profit margin by appro
Slide 39: Efficiency Strategies Lead to Optimized Profitability
Efficiency Strategies Lead to Optimized Profitability Key COGS Cost Components to Revenue Ratios ▪ In FY 2025, CHG demonstrated strong discipline in managing its Cost of Goods Sold (COGS), which increased by 28% compared to revenue growth of 33%, reaching EGP 4,369mn. As a 22% 23% result, the Group
Slide 40: Core Business Driven Growth
Core Business Driven Growth Volume, ARP, & Revenue | Volume, ARP, & Revenue | Volume, ARP, & Revenue | Surgeries Outpatients Laboratory EGP 24,951 Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. EGP 30,086 50,0 00 1,60 0 1,40 0 EGP 457 EGP 506 800 2,50 0 EGP 249 EGP 314 900
Slide 41: Balance Sheet Highlights
Balance Sheet Highlights CAPEX Profile and Cash Flow Highlights ▪ In 2025, The Group maintained its focus on network expansion and upgrades, with CAPEX outlays reaching c. EGP 2,650 million. ▪ Around 94% of spending related to assets for projects currently under construction. ▪ The largest share was
Slide 42: CLHO.CA Share Performance
CLHO.CA Share Performance CHG’s Price Performance | Rebased to 100 Valuation Multiples 1 Month VWAP Closing March 31st 20 12.64 12.08 12.4x 10.8x 18 8.9x 8.0x 7.6x 7.9x EV/EBITDA 16 Valuation 14 Multiples (x) Volume (mn) 12 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 10 8 6 29.8x 23.8x 4 17.7x P
Slide 43: Appendix: Financial Statements
Appendix: Financial Statements 43
Slide 44: Consolidated Income Statement
Consolidated Income Statement Income Statement | EGP mn 4Q2024 4Q2025 % Change FY2024 FY2025 % Change Revenues 1,588.3 1,907.0 20.1% 5,420.4 7,227.3 33.3% Cost of sales (983.0) (1,132.8) 15.2% (3,407.1) (4,368.8) 28.2% Gross profit 605.3 774.2 27.9% 2,013.3 2,858.5 42.0% Gross Profit Margin 38.1% 40
Slide 45: Consolidated Balance Sheet
Consolidated Balance Sheet Balance Sheet | EGP mn a 31 December 2024 31 December 2025 Non-current assets Fixed assets 4,642.2 7,072.9 Intangible assets 405.2 403.2 Right of use 75.6 132.9 Revenue Share Down Payment - 250.3 Investment in associates 8.5 - Total non-current assets 5,131.6 7,877.9 Curre
Slide 46: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement | EGP 31 December 2024 31 December 2025 Cash flow from operating activities: Profit before tax 1,083.7 1,319.1 Adjustments for: Depreciation 182.2 217.6 Amortization of intangible assets 2.1 2.1 Allowance for impairment of current assets 51.8 117.
Slide 47: Appendix: Photo Library
Appendix: Photo Library 47
Slide 48: Cleopatra Hospital
CHG Cleopatra Hospital 48
Slide 49: Cairo Specialized Hospital
Cairo Specialized Hospital 49
Slide 50: Nile Badrawi Hospital
| Nile Badrawi Hospital 50
Slide 51: Al Shorouk Hospital
CHG Al Shorouk Hospital 51
Slide 52: Cleopatra October Hospital
Cleopatra October Hospital 52
Slide 53: Cleopatra El Tagamoa Hospital
Cleopatra El Tagamoa Hospital 53
Slide 54: El Katib Hospital
El Katib Hospital 54
Slide 55: Bedaya Hospital
Bedaya Hospital 55
Slide 56: Cleopatra Clinics (East Cairo)
Cleopatra Clinics (East Cairo) 56
Slide 57: Cleopatra Clinics (West Cairo)
Cleopatra Clinics (West Cairo) 57
Slide 58: Cleopatra Clinics (Maadi)
Cleopatra Clinics (Maadi) 58
Slide 59: Cleopatra Clinics (Mohandesin / Al Shorouk Hospital)
Cleopatra Clinics (Mohandesin / Al Shorouk Hospital) 59
Slide 60: Cleopatra Clinics (Suez Governorate)
Cleopatra Clinics (Suez Governorate) 60
Slide 61: Cleopatra Clinics (Pyramids Clinic)
Cleopatra Clinics (Pyramids Clinic) 61
Slide 62: Thank you
Thank you INVESTOR RELATIONS CONTACTS SHAREHOLDER INFORMATION ir@cleohc.com Email: ir@cleohc.com https://www.cleopatrahospitals.com/en/investors/ EGX: CLHO.CA Website: https://www.cleopatrahospitals.com/en/investors/ Listed: June 2016 Shares Outstanding: 1.4 billion 62
Cleopatra Hospitals Group — Investor Presentation (2026) on 6ix